Research and Markets: Research Report: Orphan Drugs for Cancer Pipeline Analysis

04-11-2013 Business Wire HealthComments (0)


Research and Markets ( has announced the addition of the "Orphan Drugs for Cancer Pipeline Analysis" report to their offering. A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clini

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top